DK1366039T3 - Piperazinylcarbonylquinoliner og -isoquinoliner - Google Patents
Piperazinylcarbonylquinoliner og -isoquinolinerInfo
- Publication number
- DK1366039T3 DK1366039T3 DK01273302T DK01273302T DK1366039T3 DK 1366039 T3 DK1366039 T3 DK 1366039T3 DK 01273302 T DK01273302 T DK 01273302T DK 01273302 T DK01273302 T DK 01273302T DK 1366039 T3 DK1366039 T3 DK 1366039T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperazinylcarbonylquinolines
- isoquinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10102053A DE10102053A1 (de) | 2001-01-17 | 2001-01-17 | Piperazinylcarbonylchinoline und -isochinoline |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1366039T3 true DK1366039T3 (da) | 2006-01-02 |
Family
ID=7670921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01273302T DK1366039T3 (da) | 2001-01-17 | 2001-12-24 | Piperazinylcarbonylquinoliner og -isoquinoliner |
Country Status (23)
Country | Link |
---|---|
US (1) | US7329749B2 (da) |
EP (1) | EP1366039B1 (da) |
JP (1) | JP4417624B2 (da) |
KR (1) | KR100854481B1 (da) |
CN (1) | CN1249055C (da) |
AR (1) | AR035682A1 (da) |
AT (1) | ATE304010T1 (da) |
BR (1) | BR0116774A (da) |
CA (1) | CA2434773C (da) |
CZ (1) | CZ304144B6 (da) |
DE (2) | DE10102053A1 (da) |
DK (1) | DK1366039T3 (da) |
ES (1) | ES2248230T3 (da) |
HK (1) | HK1061849A1 (da) |
HU (1) | HU230250B1 (da) |
MX (1) | MXPA03006360A (da) |
MY (1) | MY127293A (da) |
PL (1) | PL212087B1 (da) |
RU (1) | RU2280034C2 (da) |
SI (1) | SI1366039T1 (da) |
SK (1) | SK287333B6 (da) |
WO (1) | WO2002057256A1 (da) |
ZA (1) | ZA200306331B (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040043457A1 (en) * | 2001-01-18 | 2004-03-04 | Silke Schumacher | Bifunctional fusion proteins with glucocerebrosidase activity |
DE60322869D1 (de) * | 2002-04-22 | 2008-09-25 | Univ Johns Hopkins | Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen |
WO2004002965A1 (de) * | 2002-06-29 | 2004-01-08 | Zentaris Gmbh | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen |
WO2006010515A2 (en) * | 2004-07-29 | 2006-02-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
WO2012031383A1 (zh) * | 2010-09-06 | 2012-03-15 | 中国科学院广州生物医药与健康研究院 | 酰胺类化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970714A (en) * | 1989-01-05 | 1990-11-13 | International Business Machines Corp. | Adaptive data link protocol |
WO1999002520A1 (fr) * | 1997-07-07 | 1999-01-21 | Kowa Co., Ltd. | Derives de diamine et compositions pharmaceutiques les contenant |
MXPA01002173A (es) * | 1998-08-28 | 2003-07-14 | Scios Inc | Inhibidores de p38-alfa cinasa. |
DE19934433A1 (de) * | 1999-07-22 | 2001-01-25 | Merck Patent Gmbh | N-(Indolcarbonyl-)piperazinderivate |
-
2001
- 2001-01-17 DE DE10102053A patent/DE10102053A1/de not_active Withdrawn
- 2001-12-24 MX MXPA03006360A patent/MXPA03006360A/es active IP Right Grant
- 2001-12-24 US US10/466,487 patent/US7329749B2/en not_active Expired - Fee Related
- 2001-12-24 KR KR1020037009081A patent/KR100854481B1/ko not_active IP Right Cessation
- 2001-12-24 EP EP01273302A patent/EP1366039B1/en not_active Expired - Lifetime
- 2001-12-24 CA CA2434773A patent/CA2434773C/en not_active Expired - Fee Related
- 2001-12-24 WO PCT/EP2001/015311 patent/WO2002057256A1/en active IP Right Grant
- 2001-12-24 SK SK865-2003A patent/SK287333B6/sk not_active IP Right Cessation
- 2001-12-24 DK DK01273302T patent/DK1366039T3/da active
- 2001-12-24 ES ES01273302T patent/ES2248230T3/es not_active Expired - Lifetime
- 2001-12-24 CZ CZ20031861A patent/CZ304144B6/cs not_active IP Right Cessation
- 2001-12-24 BR BR0116774-0A patent/BR0116774A/pt active Search and Examination
- 2001-12-24 PL PL361741A patent/PL212087B1/pl unknown
- 2001-12-24 JP JP2002557935A patent/JP4417624B2/ja not_active Expired - Fee Related
- 2001-12-24 DE DE60113300T patent/DE60113300T2/de not_active Expired - Lifetime
- 2001-12-24 RU RU2003124077/04A patent/RU2280034C2/ru not_active IP Right Cessation
- 2001-12-24 CN CNB018220622A patent/CN1249055C/zh not_active Expired - Fee Related
- 2001-12-24 SI SI200130444T patent/SI1366039T1/sl unknown
- 2001-12-24 AT AT01273302T patent/ATE304010T1/de active
-
2002
- 2002-01-14 MY MYPI20020115A patent/MY127293A/en unknown
- 2002-01-16 AR ARP020100135A patent/AR035682A1/es not_active Application Discontinuation
-
2003
- 2003-08-14 ZA ZA2003/06331A patent/ZA200306331B/en unknown
-
2004
- 2004-07-06 HK HK04104840A patent/HK1061849A1/xx not_active IP Right Cessation
-
2015
- 2015-10-12 HU HU0401038A patent/HU230250B1/hu not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50112013D1 (de) | Deodorantien und antiperspirantien | |
NO20031097L (no) | Kinolinderivater | |
NO20042121D0 (no) | Kinolinforbindelse | |
DE50105915D1 (de) | Schutzhülle | |
DE60212600D1 (de) | Audiocodierung und decodierung | |
NO20030795L (no) | Kinazolinderivater | |
PT1411764E (pt) | Cerca | |
NO20035121D0 (no) | Ny anvendelse | |
NO20030276L (no) | Fremgangsmåte | |
DE60208700D1 (de) | Schälgerät und zugehörige verfahren | |
NO20014597D0 (no) | Fremgangsmåte | |
DE60214306D1 (de) | Schwimbrille | |
NO20024617D0 (no) | Aryl- og heteroarylsulfonater | |
DE60117096D1 (de) | Dihydroindol- und tetrahydrochinolinderivate | |
DK1366039T3 (da) | Piperazinylcarbonylquinoliner og -isoquinoliner | |
ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
ATA18372001A (de) | Gelenksbolzenbaueinheit | |
NO20033919D0 (no) | Ny anvendelse | |
DE60205008D1 (de) | Kettelverfahren und -vorrichtung | |
DE60219418D1 (de) | Silanylphenole und -naphthole | |
DE50203221D1 (de) | Signalisierungsverfahren und -anordnung | |
ATA13992002A (de) | Schlackengranulierungsanlage | |
ATE354561T1 (de) | Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen | |
AT500276B8 (de) | Radschwenksystem | |
ATA7462001A (de) | Radspannwerk |